Renovacor Inc. (RCOR) Fundamentals

Renovacor Inc is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Its therapeutic focus is on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
SHARE INFORMATION
Market Cap$ 55,262,128
Shares Outstanding17,269,415
Float12,055,653
Percent Float69.81%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.74
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions46
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months4,471
Institutional Holdings Percent51.0%
Institutional Sold Previous 3 Months29,242
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent7.4
Insider Sold Previous 3 Months-
Insider Shares Owned1,284,025
TRADING INFO
52 Week High$ 9.74
52 Week Low$ 1.34
52 Week High Change$ -63.64
21 Day Moving Average$ 2.911
21 Day Extended Moving Average$ 2.9095
50 Day Moving Average$ 2.7376
50 Day Extended Moving Average$ 2.7218
200 Day Moving Average$ 2.8536
200 Day Extended Moving Average$ 3.4115
10 Day Average Volume27,237
20 Day Average Volume25,501
30 Day Average Volume20,479
50 Day Average Volume49,048
Alpha-0.025458
Beta-0.3311
Standard Deviation0.157725
R20.013376
7 Day Price Change$ 0.235
7 Day Percent Change7.93%
21 Day Price Change$ 0.64
21 Day Percent Change25.0%
30 Day Price Change$ 0.21
30 Day Percent Change7.02%
Month to Date Price Change$ 0.21
Month to Date Percent Change7.02%
Quarter to Date Price Change$ 0.68
Quarter to Date Percent Change26.98%
180 Day Price Change$ 1.26
180 Day Percent Change64.95%
200 Day Price Change$ 0.76
200 Day Percent Change31.15%
Year to Date Price Change$ -4.50
Year to Date Percent Change-58.44%

Renovacor Inc. (RCOR) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.30
Total Debt To Equity0.00
Int Coverage-3,296.30
Current Ratio6.60
Leverage Ratio1.30
Quick Ratio6.40
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-9.70
Enterprise Value$ 3,074,128
Price to Sales0.00
Price to Free Cash-1.80
PE High Last 5 Years0.00
Price To Book1.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-18.10
Return on Equity-27.44
Return on Capital-26.60

Renovacor Inc. (RCOR) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOMagdalene Cook
Emplyoees19
Last AuditUQ
CIK0001799850
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Nanotechnology(541713)
CONTACT INFO
AddressP.O. Box 8142
Greenwich, CT 6836
Websitehttps://www.renovacor.com
Facsimile-
Telephone+1 610 424-2650
Email-


Your Recent History
AMEX
RCOR
Renovacor
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.